Veterinary Medicine Information website

Vetivex 11 (Hartmann's) solution for infusion for cattle, horses, dogs and cats

Authorised
  • Sodium lactate
  • Sodium chloride
  • Potassium chloride
  • Calcium chloride dihydrate
Download as PDF

Product identification

Medicine name:
Vetivex 11 (Hartmann's) solution for infusion for cattle, horses, dogs and cats
Active substance:
  • Sodium lactate
  • Sodium chloride
  • Potassium chloride
  • Calcium chloride dihydrate
Target species:
  • Cattle
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Sodium lactate
    3.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium chloride
    6.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium chloride
    0.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium chloride dihydrate
    0.27
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • Polyvinylchloride infusion bag overwrapped with polypropylene.All pack sizes have two ports. Pack size: Individual fluid bag of 5000 ml, each supplied with a package leaflet
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports.Pack sizes: boxes containing 2 x 5000 ml.
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports. Pack sizes: boxes containing 15 x 500 ml
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports. Pack sizes: boxes containing 3 x 3000 ml
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports. In place of the additive port on the 5000 ml combipack is a combi port. This enables two such bags to be connected in sequence and volumes greater than 5000 ml to be administered during one infusion.Pack sizes: boxes containing 2 x 5000 ml combi.
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports. Pack sizes: boxes containing 4 x 3000 ml.
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports.Pack sizes: boxes containing 10 x 1000 ml
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports. Pack sizes: boxes containing 20 x 500 ml
  • Polyvinylchloride infusion bags overwrapped with polypropylene.All pack sizes have two ports.Pack sizes: boxes containing 20 x 250 ml
  • Polyvinylchloride infusion bag overwrapped with polypropylene.All pack sizes have two ports. In place of the additive port on the 5000 ml combipack is a combi port. This enables two such bag to be connected in sequence and volumes greater than 5000 ml to be administered during one infusion.Pack size: 5000 ml combi, each supplied with a package leaflet
  • Polyvinylchloride infusion bag overwrapped with polypropylene.All pack sizes have two ports.Pack size: Individual fluid bag of 3000 ml, each supplied with a package leaflet
  • Polyvinylchloride infusion bag overwrapped with polypropylene.All pack sizes have two ports.Pack size: Individual fluid bag of 1000 ml, each supplied with a package leaflet
  • Polyvinylchloride infusion bag overwrapped with polypropylene.All pack sizes have two ports.Pack size: Individual fluid bag of 500 ml, each supplied with a package leaflet
  • Polyvinylchloride infusion bag overwrapped with polypropylene.All pack sizes have two ports. Pack size: Individual fluid bag of 250 ml, each supplied with a package leaflet.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industria Farmaceutica Galenica Senese S.r.l.
  • Infomed Fluids S.R.L.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2198629 1/2013
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0512/001
Concerned member states:
  • Belgium
  • Denmark
  • France
  • Germany
  • Netherlands
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 20/07/2025
Download
French (PDF)
Published on: 11/07/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Download

Combined File of all Documents

English (PDF)
Published on: 20/07/2025
Download